Sports Cardiology — The Athlete’s Heart and Football’s Hidden Cardiac Risks

Introduction

Sudden cardiac death in a professional footballer during a match is a rare but devastating event — and one that has driven significant advances in cardiac screening and sports cardiology. The challenge facing sports cardiologists is distinguishing physiological cardiac adaptation (athlete’s heart) from pathological cardiac conditions that carry genuine life-threatening risk during exercise. This distinction — between healthy adaptation and dangerous pathology — is not always straightforward and requires specialised expertise that general practitioners rarely possess.

The Science

Athlete’s heart (cardiac remodelling): Sustained endurance and mixed-intensity training (football is both) produces structural and functional cardiac adaptations:

• Left ventricular (LV) hypertrophy: LV wall thickness increases 10–15% in elite athletes vs. sedentary controls
• Increased LV cavity size: Diastolic LV diameter increases (eccentric hypertrophy) — accommodating greater stroke volume
• Reduced resting heart rate: Vagal dominance from training produces resting bradycardia (40–55 bpm common; <40 bpm in extreme endurance athletes)
• Increased stroke volume: Both structural and functional adaptation allows greater blood ejection per beat

These are physiological adaptations — not risk factors. Elite footballers show significant athlete’s heart features on echocardiography.

Hypertrophic Cardiomyopathy (HCM): The most common cause of sudden cardiac death (SCD) in young athletes in the UK and USA. HCM involves asymmetric LV hypertrophy — usually affecting the interventricular septum. The phenotype can be indistinguishable from athlete’s heart on ECG and echocardiography, creating a critical diagnostic challenge. Distinguishing HCM from athletic adaptation requires:

• LV wall thickness >15mm suggests HCM (athlete’s heart rarely exceeds 13mm)
• Diastolic dysfunction (impaired LV relaxation) suggests HCM; normal or supranormal diastolic function suggests physiological adaptation
• Detraining test: athletic hypertrophy partially regresses after 3+ months detraining; HCM does not

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): A genetic condition causing fibro-fatty replacement of right ventricular myocardium — presenting as exercise-induced ventricular arrhythmia and being the most common cause of SCD in young Italian athletes (different epidemiology from UK/USA, explained by regional genetic prevalence differences). ARVC is exercise-sensitive — training accelerates progression, and competitive sport is absolutely contraindicated in established ARVC.

ECG changes in athletes: Athletes show many ECG findings that would be abnormal in non-athletes:

• Sinus bradycardia
• Incomplete right bundle branch block
• Early repolarisation (benign in athletes)
• LV hypertrophy voltage criteria

These are expected physiological adaptations — not cardiac warning signs. Pathological ECG findings requiring investigation include: T-wave inversions, ST-segment depression, and prolonged QTc interval.

What Research Says

Corrado et al. (2006) published the landmark Italian pre-participation screening outcome data in JAMA, demonstrating that mandatory ECG screening (alongside history and physical examination) implemented across Italy in 1982 was associated with an 89% reduction in SCD incidence in competitive young athletes over 25 years — establishing ECG-based screening as the most impactful cardiac safety intervention in sport.

Maron et al. (2007) reviewed SCD in young athletes in Circulation, identifying HCM as the most common cause in US athletes (36% of cases), followed by coronary artery anomalies (17%) and myocarditis (7%) — providing the epidemiological foundation for screening protocol design.

Brosnan et al. (2014) examined the grey zone of LV wall thickness in athletes using detraining protocols in JACC: Cardiovascular Imaging, demonstrating that serial echocardiography during 12 weeks of detraining reliably distinguished HCM (no regression) from athletic adaptation (significant regression) in the 13–15mm grey zone.

Did You Know? The European Society of Cardiology recommends that all competitive athletes undergo ECG-based cardiac screening every 1–2 years. The UK and many national football associations now mandate pre-participation cardiovascular screening including ECG for all professional footballers. Footballer Fabrice Muamba’s cardiac arrest during an FA Cup quarter-final in 2012 — from which he survived due to immediate defibrillation and prolonged resuscitation — transformed awareness and defibrillator provision at football venues globally. He had an underlying condition (hypertrophic cardiomyopathy) that had not been detected by his screening.

Applied to Football

Cardiac safety in football organisations:

1. Mandatory pre-participation cardiac screening including ECG for all professional and semi-professional players. History + physical examination alone misses the majority of at-risk conditions. ECG adds significant sensitivity for HCM, ARVC, and WPW detection.
2. Use sports cardiology specialists for athlete ECG interpretation. Physiological ECG changes in athletes are frequently misinterpreted as pathological by cardiologists unfamiliar with athlete-specific criteria (Seattle Criteria, 2014). Misdiagnosis causes unnecessary disqualification of healthy athletes.
3. Automated external defibrillators (AEDs) at all training and match venues. Ventricular fibrillation survival is time-dependent — survival drops 10% per minute without defibrillation. AEDs available within 3 minutes save lives.
4. Detraining protocol for LV thickness grey zone. Players with LV wall thickness 13–15mm should be referred to sports cardiology for detraining assessment before being cleared or restricted.
5. No competitive sport in confirmed ARVC. This is an absolute contraindication — not a risk-benefit discussion. Exercise accelerates ARVC progression and triggers life-threatening arrhythmia.

Key Takeaways

• Athlete’s heart features (LV hypertrophy, bradycardia, increased cavity) are physiological adaptations, not pathology
• HCM is the most common cause of SCD in young athletes — distinguished from athlete’s heart by wall thickness >15mm, diastolic dysfunction, and failure to regress with detraining
• ECG-based screening reduced SCD in Italian athletes by 89% over 25 years
• Athlete ECGs contain expected “abnormal” findings — sports cardiology specialist interpretation is required to avoid over-diagnosis
• AEDs within 3-minute access of all training and match venues are non-negotiable

References

• Corrado, D., Basso, C., Pavei, A., Michieli, P., Schiavon, M., & Thiene, G. (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA, 296(13), 1593–1601.
• Maron, B. J., Doerer, J. J., Haas, T. S., Tierney, D. M., & Mueller, F. O. (2009). Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980–2006. Circulation, 119(8), 1085–1092.
• Drezner, J. A., Ackerman, M. J., Anderson, J., Ashley, E., Asplund, C. A., Baggish, A. L., & Corrado, D. (2013). Electrocardiographic interpretation in athletes: the ‘Seattle Criteria’. British Journal of Sports Medicine, 47(3), 122–124.